- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2008-003213-27.
Displaying page 1 of 1.
EudraCT Number: 2008-003213-27 | Sponsor Protocol Number: 26866138MMY3022 | Start Date*: 2008-11-07 | |||||||||||
Sponsor Name:ORTHO BIOTECH, Division of JANSSEN-CILAG GmbH | |||||||||||||
Full Title: Randomized Phase III Study on Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma | |||||||||||||
Medical condition: Refractory or relapsed multiple myeloma after 1 to 3 previous lines of therapy, including high-dose therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
